后循环闭塞血管内治疗前静脉溶栓:MR CLEAN登记研究
该研究基于荷兰全国性前瞻性多中心MR CLEAN登记,纳入2014至2019年因后循环大血管闭塞接受血管内治疗的患者248例,比较血管内治疗前接受静脉溶栓(125例)与未接受静脉溶栓(123例)患者的临床、技术和安全性结局,发现两组在90天改良Rankin量表评分偏移、症状性颅内出血、成功再灌注、良好功能结局和死亡率方面均无显著差异。
要点
- 后循环闭塞血管内治疗前静脉溶栓与未溶栓相比,90天改良Rankin量表评分偏移无显著差异(校正共同比值比1.04,95%CI 0.61-1.76)。
- 症状性颅内出血静脉溶栓组4.8% versus 未溶栓组2.4%,校正比值比1.65(95%CI 0.33-8.35),未达统计学显著。
- 成功再灌注、良好功能结局、首次尝试成功再灌注和死亡率在两组间均无显著差异。
核心结论
- 后循环大血管闭塞患者血管内治疗前接受或不接受静脉溶栓,在临床、技术和安全性结局方面均无显著差异,结果与前循环文献一致。
研究设计与样本
- 研究为荷兰全国性前瞻性多中心登记(MR CLEAN登记),纳入2014至2019年因颅内大血管闭塞导致急性缺血性卒中并接受血管内治疗的患者。
- 共纳入后循环闭塞患者248例,其中血管内治疗前接受静脉溶栓125例,未接受静脉溶栓123例。
- 主要结局为90天改良Rankin量表评分向更好功能结局的偏移;次要结局包括良好功能结局(改良Rankin量表评分0-3分)、症状性颅内出血、成功再灌注(扩展脑缺血溶栓分级≥2B)、首次尝试成功再灌注和90天死亡率。
- 采用基于单变量分析和文献的校正回归分析。
主要发现
- 90天改良Rankin量表评分偏移:静脉溶栓组 versus 未溶栓组校正共同比值比1.04(95%CI 0.61-1.76),无显著差异。
- 症状性颅内出血:静脉溶栓组4.8% versus 未溶栓组2.4%,校正比值比1.65(95%CI 0.33-8.35),回归分析未显示显著差异。
- 成功再灌注、良好功能结局、首次尝试成功再灌注和死亡率在静脉溶栓组与未溶栓组之间均无显著差异。
关键数值与推荐
- 主要结局为90天改良Rankin量表评分偏移,校正共同比值比1.04(95%CI 0.61-1.76)。
- 症状性颅内出血静脉溶栓组4.8% versus 未溶栓组2.4%,校正比值比1.65(95%CI 0.33-8.35)。
- 良好功能结局定义为改良Rankin量表评分0-3分。
- 成功再灌注定义为扩展脑缺血溶栓分级≥2B。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effectiveness of intravenous thrombolysis (IVT) before endovascular treatment (EVT) has been investigated in randomized trials and meta-analyses. These studies mainly concerned anterior circulation occlusions. We aimed to investigate clinical, technical, and safety outcomes of IVT before EVT in posterior circulation occlusions in a nationwide registry. METHODS: Patients were included from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), a nationwide, prospective, multicenter registry of patients with acute ischemic stroke due to a large intracranial vessel occlusion receiving EVT between 2014 and 2019. All patients with a posterior circulation occlusion were included. Primary outcome was a shift toward better functional outcome on the modified Rankin Scale at 90 days. Secondary outcomes were favorable functional outcome (modified Rankin Scale scores, 0-3), occurrence of symptomatic intracranial hemorrhages, successful reperfusion (extended Thrombolysis in Cerebral Ischemia ≥2B), first-attempt successful reperfusion, and mortality at 90 days. Regression analyses with adjustments based on univariable analyses and literature were applied. RESULTS: A total of 248 patients were included, who received either IVT (n=125) or no IVT (n=123) before EVT. Results show no differences in a shift on the modified Rankin Scale (adjusted common odds ratio, 1.04 [95% CI, 0.61-1.76]). Although symptomatic intracranial hemorrhages occurred more often in the IVT group (4.8% versus 2.4%), regression analysis did not show a significant difference (adjusted odds ratio, 1.65 [95% CI, 0.33-8.35]). Successful reperfusion, favorable functional outcome, first-attempt successful reperfusion, and mortality did not differ between patients treated with and without IVT. CONCLUSIONS: We found no significant differences in clinical, technical, and safety outcomes between patients with a large vessel occlusion in the posterior circulation treated with or without IVT before EVT. Our results are in line with the literature on the anterior circulation.
引用
- Knapen RRMM, Pirson FAV, Langezaal LCM, et al. Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions: A MR CLEAN Registry Study. Stroke. 2024. PMID: 38174571. doi:10.1161/STROKEAHA.123.043777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。